$403,000 Federal Contract Awarded to 3D Imaging Drug Design& Development

Targeted News Service |

By Targeted News Service WASHINGTON, June 26 -- 3D Imaging Drug Design& Development, North Little Rock, Arkansas, won a $403,000 federal contract from the U.S. Department of Health and Human Services' Food and Drug Administration, Rockville, Maryland, for radioactive-labeled tracer synthesis. For more information about Targeted News Service's products, including its daily federal contract report, please contact: Myron Struck, Myron@targetednews.com, Editor, Targeted News Service LLC, Springfield, Va., Direct: 703/866-4708, Cell: 703/304-1897. 30VitinMar140626-mv-742438 30VitinMar

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
SPOMD Spo Global Inc n/a n/a n/a 0

Comments

Emerging Growth

PixarBio Corp

PixarBio Corp is a specialty pharmaceutical/biotechnology company focused on pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain.

Private Markets

Uber

Uber connects riders with safe, reliable, convenient transportation providers at a variety of price-points in cities around the world. Uber makes money from charging their drivers 20% of the fare…

Ozobot by Evollve Inc

Ozobot is a world leader in compact super intelligent robots that entertain and educate through fun interactive gaming.